New Zealand markets open in 4 hours 3 minutes

Poseida Therapeutics, Inc. (PSTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.4700-0.0900 (-3.52%)
As of 12:49PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
88,462
64,703
130,492
31,238
0
Operating expenses
Research development
167,996
156,772
152,899
136,734
103,520
Selling general and administrative
38,932
37,435
37,539
35,915
23,029
Total operating expenses
206,928
194,207
190,438
172,649
126,549
Operating income or loss
-118,466
-129,504
-59,946
-141,411
-126,549
Interest expense
9,014
8,671
6,370
3,358
3,506
Total other income/expenses net
14,815
14,852
2,858
19,795
280
Income before tax
-112,665
-123,323
-63,458
-124,974
-129,775
Income tax expense
-
107
544
0
0
Income from continuing operations
-112,772
-123,430
-64,002
-124,974
-129,775
Net income
-112,772
-123,430
-64,002
-124,974
-129,775
Net income available to common shareholders
-112,772
-123,430
-64,002
-124,974
-129,775
Basic EPS
-1.54
-1.37
-0.89
-2.01
-3.61
Diluted EPS
-1.54
-1.37
-0.89
-2.01
-3.61
Basic average shares
87,768
90,185
71,954
62,236
35,997
Diluted average shares
87,768
90,185
71,954
62,236
35,997